BigHat Biosciences is reimagining antibody discovery and engineering with an AI-first experimental platform that integrates a high-speed wet lab with machine learning to create better antibodies faster and undertake novel designs far beyond what’s possible today.
Location: United States, California, San Mateo
Employees: 11-50
Total raised: $94M
Founded date: 2019
Investors 7
| Date | Name | Website |
| - | Old Silver... | oldsilverv... |
| - | S32 | s32.com |
| - | Flucas Ven... | flucasvc.c... |
| - | 8VC | 8vc.com |
| - | Olima Vent... | olima.vc |
| 07.01.2022 | MBC BioLab... | mbcbiolabs... |
| - | Axial VC | axialvc.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.07.2022 | Series B | $75M | - |
| 10.02.2021 | Series A | $19M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 29.11.2022 | BigHat Biosciences Announces Research Collaboration with Mer... | Collaboration leverages BigHat’s AI-enabled platform to expedite protein engineering to design and d... | aithority.... |
| 21.07.2022 | BigHat Biosciences Raises $75 Million in Series B Funding to... | Capital will advance BigHat’s internal pipeline of therapeutics to patients, expand platform capacit... | aithority.... |
| 21.07.2022 | A first-time VC raised $2 million in 2 months to invest in w... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 20.07.2022 | BigHat Biosciences Raises USD75M Series B Funding Round | BigHat Biosciences, a San Mateo, CA-based biotechnology company developing antibody therapies for pa... | finsmes.co... |
| 20.07.2022 | BigHat Biosciences Raises $75M in Series B | SAN MATEO, CA, BigHat Biosciences, a biotechnology company, has raised a $75 million Series B fund... | vcnewsdail... |
| 11.02.2021 | BigHat Biosciences Raises $19 Million in Series A Funding to... | Andreessen Horowitz-led investment fuels hiring and R&D for AI-enabled experimental platform tha... | aithority.... |
| 10.02.2021 | BigHat Biosciences bags $19M to 'supercharge' antibody devel... | Monoclonal antibodies have transformed the treatment of many diseases from cancer to autoimmune diso... | fiercebiot... |
| 10.02.2021 | BigHat raises $19 million for an AI-powered antibody design ... | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 10.02.2021 | BigHat Biosciences Seeks Better Biotech Drugs With $19 Milli... | Biotechnology startup BigHat Biosciences Inc. has raised $19 million in fresh capital to pursue its ... | wsj.com/ar... |
| 10.02.2021 | BigHat Biosciences Raises $19M in Series A Funding | BigHat Biosciences, a San Carlos, Calif.-based novel protein therapeutics company and developer of a... | finsmes.co... |
Show more